CollPlant Biotechnologies GAAP EPS of -$0.87, revenue of $11.43M; reaffirms FY 2026 outlook
Breaking News on Seeking Alpha
This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.
Read at original outlet ↗This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.
Read at original outlet ↗